logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Cap Biotech: The company currently does not have any HanTan virus-related testing reagent products.

date
12/05/2026
On May 12, Cap Biotechnology stated on the interactive platform that the company currently does not have Han Tan virus related test kit products, but its medical testing laboratory has the corresponding testing capabilities.
Latest
1 m ago
Hengrui Medicine (600276.SH) signs strategic cooperation and licensing agreement with Novartis AG company.
2 m ago
Galaxy Entertainment (00027.HK) reported a net profit of 12.4 billion Hong Kong dollars in the first quarter, up 11% year-on-year.
3 m ago
The US appears to tacitly approve of yen intervention, clues revealed in meeting between Japanese finance minister and Bentsen
4 m ago
Perutz's subsidiary Trian is currently in negotiations to raise funds for the privatization acquisition of Wendy Hamburg.
6 m ago
Hengrui Medicine (01276) signed a strategic cooperation and licensing agreement with Roche.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.